Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2026-05-18 @ 10:21 AM
Study NCT ID:
NCT00002420
Status:
TERMINATED
Last Update Posted:
2008-08-14
First Post:
1999-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Sponsor:
Bristol-Myers Squibb
Organization: